Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common shares (LCTX)
CUSIP: 53566P109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common shares
- Shares outstanding
- 250,425,788
- Total 13F shares
- 94,431,242
- Share change
- +863,810
- Total reported value
- $94,175,668
- Put/Call ratio
- 1.3%
- Price per share
- $1.00
- Number of holders
- 110
- Value change
- +$447,460
- Number of buys
- 39
- Number of sells
- 35
Report period
Q2 2024
Institutions
110
Top holders
10
LCTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Ownership snapshot
Top shareholders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BROADWOOD CAPITAL INC
13D/G signal
—
Evidence rows
50
Latest as of
31 Mar 2024
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
17%
|
$61,666,057
41,666,255 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
3.4%
|
$12,571,703
8,494,395 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$12,393,182
8,373,771 shares
|
— | 31 Mar 2024 |
| Logos Global Management LP |
13F
Company
|
2.5%
|
$9,250,000
6,250,000 shares
|
— | 31 Mar 2024 |
| Defender Capital, LLC. |
13F
Company
|
2%
|
$7,352,159
4,967,675 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.3%
|
$4,815,189
3,253,056 shares
|
— | 31 Mar 2024 |
| RAFFLES ASSOCIATES LP |
13F
Company
|
1.3%
|
$4,750,772
3,209,981 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
0.87%
|
$3,222,269
2,177,209 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
110
Shares
94,431,242
Rows loaded
110
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
113
Q2 2024 holders
110
Holder diff
-3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend